Literature DB >> 3079090

A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.

S J Forman1, K G Blume, R A Krance, P J Miner, G E Metter, L R Hill, M R O'Donnell, A P Nademanee, D S Snyder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3079090

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

Review 1.  Intestinal graft-versus-host disease: mechanisms and management.

Authors:  Hiroyuki Takatsuka; Tsuyoshi Iwasaki; Takahiro Okamoto; Eizo Kakishita
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Prevention and management of graft-versus-host disease. Practical recommendations.

Authors:  G B Vogelsang; L E Morris
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

3.  Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remission.

Authors:  A P Nademanee; S J Forman; G M Schmidt; P J Bierman; D S Snyder; M R O'Donnell; J A Lipsett; K G Blume
Journal:  Blut       Date:  1987-07

4.  High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies.

Authors:  K G Blume; S J Forman
Journal:  Blut       Date:  1987-07

5.  Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.

Authors:  D S Snyder; D O Findley; S J Forman; A P Nademanee; M R O'Donnell; G M Schmidt; P J Bierman; J L Fahey; R A Krance; I J Sniecinski
Journal:  Blut       Date:  1988-07

6.  Development of a single probe for documentation of chimerism following bone marrow transplantation.

Authors:  P Yam; L D Petz; S Ali; A D Stock; R B Wallace
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

7.  Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation.

Authors:  K B Miller; D P Schenkein; R Comenzo; J K Erban; T Fogaren; C A Hirsch; E Berkman; A Rabson
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.